Synergistic Effects of Combination Treatment with Bortezomib and Doxorubicin in Human Neuroblastoma Cell Lines
Authors:
- Wei SongWSWei Song
- Lu BaiLBLu Bai
- Yan ShenYSYan Shen
- Shi-Ying MiaoSMShi-Ying Miao
- Lin-Fang WangLWLin-Fang Wang
- 11 February 2012
- journal article
- research article
- Published by S. Karger AG in Chemotherapy
- Vol. 58 (1) , 44-51
Abstract
Background: Neuroblastoma (NB) is the most common extracranial solid tumor in infants. Currently, the mainstay of NB chemotherapy is combination treatment with some traditional drugs, but these combination regimens are always inefficient. Methods: The aim of this study was to evaluate the inhibitory effect of a combination of doxorubicin and bortezomib, a novel anticancer drug and the first prote-asome inhibitor approved for the treatment of human malignant tumors, on the proliferation of two human NB cell lines, SK-N-SH and SH-SY5Y. The general mechanism underlying this combined effect was also investigated. Synergistic inhibitory effects on human NB cell proliferation were evaluated using the median-effect principle. The pro-apoptotic effects of these drugs were evaluated using double staining with annexin-V-FITC and propidium iodide. Results: Synergistic inhibitory effects on proliferation were observed when a combination of bortezomib and doxorubicin was applied to cultured NB cells. A similar synergistic effect on apoptosis was also observed when the two drugs were used concurrently, which suggested that the possible mechanism underlying the observed synergistic inhibitory effect might be related to apoptosis. Conclusion: The combination of bortezomib and doxorubicin appears to be a promising strategy to treat NB.Keywords
This publication has 30 references indexed in Scilit:
- Molecular Mechanism of Cell Apoptosis by Paclitaxel and Pirarubicin in a Human Osteosarcoma Cell LineChemotherapy, 2010
- A Phase I Study of Pegylated Liposomal Doxorubicin and Irinotecan in Patients with Solid TumorsChemotherapy, 2009
- New approaches to pharmacotherapy of tumors of the nervous system during childhood and adolescencePharmacology & Therapeutics, 2009
- New therapeutic targets for the treatment of high‐risk neuroblastomaJournal of Cellular Biochemistry, 2009
- Effect of bortezomib on human neuroblastoma: analysis of molecular mechanisms involved in cytotoxicityMolecular Cancer, 2008
- Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination StudiesPharmacological Reviews, 2006
- Differential Regulation of Noxa in Normal Melanocytes and Melanoma Cells by Proteasome Inhibition: Therapeutic ImplicationsCancer Research, 2005
- Rapamycin inhibits doxorubicin-induced NF-κB/Rel nuclear activity and enhances the apoptosis of melanoma cellsEuropean Journal of Cancer, 2004
- Activation of nuclear factor-κB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxideBiochemical Journal, 2002
- NF-κB Activation Mediates Doxorubicin-induced Cell Death in N-type Neuroblastoma CellsJournal of Biological Chemistry, 2001